Remus Pharmaceuticals Ltd.

•

remuspharma.comBSE: -NSE: REMUS

Market Cap₹ 1,054 Cr.

Current Price

High / Low₹ 988 / 580

Stock P/E42.6

Book Value₹ 276

Price to Book5.44

Dividend Yield0.11 %

ROCE13.5 %

ROE10.1 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 35.8%
Company has a good return on equity (ROE) track record: 3 Years ROE 31.8%
Company has delivered good sales growth of 46.0% CAGR over last 5 years
Operating margins have improved to 32.8% from 19.6%

CONS

Total debt has risen sharply - up 48.6% year on year
Stock is trading at 5.4x its book value
Inventory has been piling up - inventory days up from 6 to 9
Rich enterprise valuation - EV/EBITDA of 45.6x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2886.00	52.48	390684.34	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	1002.00	27.32	45485.94	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	AEGISLOG	1286.15	36.08	45143.87	0.68	544.84	210.70	2356.86	37.07	19.76	30.28
4.	CPPLUS	3748.55	92.91	44345.51	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
5.	REDINGTON	372.40	17.12	29113.28	1.61	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	477.45	62.55	15566.03	0.63	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	71.95	97.81	10983.54	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	814.50	82.57	10265.57	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.28	20.88	9342.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1847.60	64.12	8041.32	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	343.50	24.77	7747.24	0.44	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	REMUS	894.10	28.48	1053.61	0.11	—	—	—	—	21.89	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

No standalone quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	12	18	25	45	64	79
	12	18	21	34	43	53
Operating Profit	0	1	4	11	21	26
OPM %	3.29%	4.14%	16.74%	23.42%	32.84%	32.82%
	1	1	1	2	3	3
Interest	0	0	0	0	0	0
Depreciation	0	0	0	0	1	2
Profit before Tax	1	1	5	11	22	27
Tax %	25.81%	24.47%	25.56%	25.50%	25.64%	25.30%
Net Profit	1	1	3	9	17	20
EPS	8.12	10.26	34.34	83.24	113.06	33.79
Dividend Payout %	0.00%	0.00%	0.00%	2.55%	5.31%	4.44%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 46%
3 Years:: 47%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 90%
3 Years:: 80%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: 18%
1 Year:: 1%

RETURN ON EQUITY

10 Years:: —
5 Years:: 41%
3 Years:: 32%
Last Year:: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0	0	1	1	1	6
	2	3	6	18	152	236
	0	0	0	8	3	3
Trade Payables	1	5	5	4	8	5
	2	3	4	4	18	30
Total Liabilities	5	11	16	35	183	280
	1	0	0	3	5	7
	0	0	3	21	127	209
	0	1	2	0	2	2
	0	0	0	0	15	16
Cash & Bank	1	1	1	3	11	4
	3	9	10	8	24	42
Total Assets	5	11	16	35	183	280

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	2	3	6	8	6	16
Cash from Investing	-1	-3	-5	-15	-47	-12
Cash from Financing	0	-0	-0	12	42	-1
	1	-0	0	2	1	2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	811.60	1025.80	34.34	78.37	113.06	33.79
Book Value (₹)	2020.30	3046.10	65.78	176.36	1044.56	411.24
Dividend per Share (₹)	0.00	0.00	0.00	2.00	6.00	1.50
Cash EPS (₹)	1.15	1.50	4.49	10.35	15.09	18.48
PROFITABILITY
Operating Margin %	10.42%	8.51%	19.64%	26.93%	32.84%	32.82%
Net Margin %	6.81%	5.57%	13.89%	18.88%	25.99%	25.14%
ROE %	40.17%	40.49%	71.37%	66.14%	19.25%	10.06%
ROCE %	47.76%	48.84%	93.13%	68.82%	24.92%	13.53%
	15.38%	12.61%	25.62%	33.77%	15.25%	8.58%
EFFICIENCY
Debtor Days	50	52	48	31	56	70
Inventory Days	13	16	20	8	6	9
Payable Days	68	103	146	70	77	69
	-5	-35	-78	-31	-15	10
FINANCIAL HEALTH
Debt to Equity (x)	0.18x	0.09x	0.03x	0.42x	0.01x	0.01x
Interest Coverage (x)	26.74x	39.69x	53.91x	50.09x	66.74x	71.11x
	1.63x	0.98x	0.84x	1.39x	3.28x	4.87x
GROWTH
Revenue Growth %	0.00%	54.53%	34.13%	82.27%	42.00%	23.80%
Operating Profit Growth %	0.00%	26.22%	209.62%	149.70%	96.39%	21.34%
Net Profit Growth %	0.00%	26.39%	234.77%	147.60%	95.47%	19.74%
	0.00%	0.00%	0.00%	0.00%	44.27%	-70.12%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	7.63x	33.13x
P/B (x)	0.00x	0.00x	0.00x	0.00x	6.61x	5.44x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.09%	0.07%
	0.00x	0.00x	0.00x	0.00x	42.20x	45.57x

Shareholding Pattern

Numbers in percentages

	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	69.61	70.60	70.84	70.85	70.91	70.95
	2.38	3.25	3.16	4.77	5.02	5.28
	0.71	0.67	0.77	0.77	0.77	0.83
Government	0.00	0.00	0.00	0.00	0.00	0.00
	27.30	25.49	25.22	23.60	23.31	22.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for REMUS

Loading news…

🤖

AI Stock Analyst

Remus Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2886.00

52.48

390684.34

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

1002.00

27.32

45485.94

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

AEGISLOG

1286.15

36.08

45143.87

0.68

544.84

210.70

2356.86

37.07

19.76

30.28

CPPLUS

3748.55

92.91

44345.51

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

REDINGTON

372.40

17.12

29113.28

1.61

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

477.45

62.55

15566.03

0.63

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

71.95

97.81

10983.54

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

814.50

82.57

10265.57

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.28

20.88

9342.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1847.60

64.12

8041.32

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

343.50

24.77

7747.24

0.44

73.40

-8.99

526.72

-0.43

17.15

18.80

REMUS

894.10

28.48

1053.61

0.11

—

21.89

—

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Operating Profit

OPM %

3.29%

4.14%

16.74%

23.42%

32.84%

32.82%

Interest

Depreciation

Profit before Tax

Tax %

25.81%

24.47%

25.56%

25.50%

25.64%

25.30%

Net Profit

EPS

8.12

10.26

34.34

83.24

113.06

33.79

Dividend Payout %

0.00%

2.55%

5.31%

4.44%

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

152

236

Trade Payables

Total Liabilities

183

280

127

209

Cash & Bank

Total Assets

183

280

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-1

-3

-5

-15

-47

-12

Cash from Financing

-0

-1

-0

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

811.60

1025.80

34.34

78.37

113.06

33.79

Book Value (₹)

2020.30

3046.10

65.78

176.36

1044.56

411.24

Dividend per Share (₹)

0.00

2.00

6.00

1.50

Cash EPS (₹)

1.15

1.50

4.49

10.35

15.09

18.48

PROFITABILITY

Operating Margin %

10.42%

8.51%

19.64%

26.93%

32.84%

32.82%

Net Margin %

6.81%

5.57%

13.89%

18.88%

25.99%

25.14%

ROE %

40.17%

40.49%

71.37%

66.14%

19.25%

10.06%

ROCE %

47.76%

48.84%

93.13%

68.82%

24.92%

13.53%

15.38%

12.61%

25.62%

33.77%

15.25%

8.58%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

103

146

-5

-35

-78

-31

-15

FINANCIAL HEALTH

Debt to Equity (x)

0.18x

0.09x

0.03x

0.42x

0.01x

Interest Coverage (x)

26.74x

39.69x

53.91x

50.09x

66.74x

71.11x

1.63x

0.98x

0.84x

1.39x

3.28x

4.87x

GROWTH

Revenue Growth %

0.00%

54.53%

34.13%

82.27%

42.00%

23.80%

Operating Profit Growth %

0.00%

26.22%

209.62%

149.70%

96.39%

21.34%

Net Profit Growth %

0.00%

26.39%

234.77%

147.60%

95.47%

19.74%

0.00%

44.27%

-70.12%

VALUATION

P/E (x)

0.00x

7.63x

33.13x

P/B (x)

0.00x

6.61x

5.44x

Dividend Yield %

0.00%

0.09%

0.07%

0.00x

42.20x

45.57x

Sep 2023

Mar 2024

Sep 2024

Mar 2025

Sep 2025

Mar 2026

69.61

70.60

70.84

70.85

70.91

70.95

2.38

3.25

3.16

4.77

5.02

5.28

0.71

0.67

0.77

0.83

Government

0.00

27.30

25.49

25.22

23.60

23.31

22.94

Remus Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Remus Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI